Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 11, 2026

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

463

Bupropion for weight reduction.

Kishore M Gadde1, Glen L Xiong

  • 1Duke University Medical Centre, Box 3292, Durham, NC 27710, USA. gadde001@mc.duke.edu

Expert Review of Neurotherapeutics
|December 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mazdutide and Orforglipron-New Evidence in Obesity and Diabetes.

JAMA·2026
Same author

How does prior infection and vaccination relate to the risk of incident SARS-CoV-2 infection/reinfection? A prospective cohort study among nine clinical sites in the USA, February 2021 to January 2023.

BMJ open·2026
Same author

Bridging the Educational Gap in Behavioral Sleep Medicine: Enhancing Primary Care Management of Sleep Disorders.

Behavioral sleep medicine·2026
Same author

Antidepressants and bleeding risk: Expert consensus from the Association of Medicine and Psychiatry.

Journal of psychosomatic research·2026
Same author

Association of GERD with Sleeve Gastrectomy: An Unintended Consequence.

Current diabetes reports·2026
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

An overview of the safety and efficacy of sphenopalatine ganglion stimulation for the treatment of chronic cluster headache.

Expert review of neurotherapeutics·2026
Same journal

Multiomics and proteomic insights into Alzheimer's disease biology in Down syndrome.

Expert review of neurotherapeutics·2026
Same journal

Remote deep brain stimulation programming in childhood dystonia: opportunities, challenges, and future directions.

Expert review of neurotherapeutics·2026
Same journal

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

Expert review of neurotherapeutics·2026
Same journal

Corticosteroids in withdrawal therapy following medication-overuse headache: a systematic review.

Expert review of neurotherapeutics·2026
Same journal

Clinical efficacy of lacosamide in neuropathic pain: a systematic review of randomized controlled trials.

Expert review of neurotherapeutics·2026
See all related articles

Bupropion, a norepinephrine and dopamine reuptake inhibitor, shows efficacy for weight loss in obese patients, despite not being FDA-approved for this indication. This review covers its pharmacology, clinical evidence, and role in obesity management.

Area of Science:

  • Pharmacology
  • Clinical Trials
  • Obesity Management

Background:

  • Bupropion is a norepinephrine and dopamine reuptake inhibitor.
  • It is approved for depression and smoking cessation.
  • Its efficacy for obesity management is under investigation.

Purpose of the Study:

  • To review the pharmacology of bupropion.
  • To examine clinical evidence for bupropion's efficacy in weight reduction.
  • To discuss the tolerability, risks, and future role of bupropion in obesity management.

Main Methods:

  • Review of existing randomized clinical trials.
  • Analysis of pharmacological data.
  • Assessment of safety and tolerability profiles.

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

885
Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.4K

Related Experiment Videos

Last Updated: Jan 11, 2026

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

463
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

885
Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.4K

Main Results:

  • Three randomized clinical trials indicate bupropion's efficacy in promoting weight loss in obese individuals.
  • Pharmacological profile supports its potential role in weight management.
  • Tolerability and risk data are crucial for clinical application.

Conclusions:

  • Bupropion demonstrates potential as a treatment for obesity, warranting further investigation.
  • Understanding its pharmacology and clinical evidence is key to its role in obesity management.
  • Continued research will define bupropion's place in treating obesity.